Online inquiry

IVTScrip™ mRNA-Human APOBEC3H, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23124MR)

This product GTTS-WK23124MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the APOBEC3H protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001166002.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 164668
UniProt ID Q6NTF7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APOBEC3H, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23124MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK13172MR IVTScrip™ mRNA-Human ADSS, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADSS
GTTS-WK25766MR IVTScrip™ mRNA-Human ATL1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATL1
GTTS-WK5614MR IVTScrip™ mRNA-Human RPE65, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA RPE65
GTTS-WK0823MR IVTScrip™ mRNA-Human DCLK1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA DCLK1
GTTS-WK13726MR IVTScrip™ mRNA-Human ADCYAP1R1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADCYAP1R1
GTTS-WK8759MR IVTScrip™ mRNA-Human ABHD10, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABHD10
GTTS-WK9109MR IVTScrip™ mRNA-Human ACADSB, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ACADSB
GTTS-WK21078MR IVTScrip™ mRNA-Human AKR1D1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AKR1D1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →